Ruth Oliver

Ruth Oliver

Auto-generated profile, based on publicly available information

Ruth Oliver

School of Engineering, Macquarie University, Sydney, Australia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2019 in IEEE Reviews in Biomedical Engineering
Verified
Journal Article
Closed access
MGMina Ghaffari
Mina Ghaffari
ASArcot Sowmya
Arcot Sowmya
RORuth Oliver
Ruth Oliver
Reliable brain tumor segmentation is essential for accurate diagnosis and treatment planning. Since manual segmentation of brain tumors is a highly time-consuming, expensive and subjective task, practical automated methods for this purpose are greatly appreciated. But since brain tumors are highly heterogeneous in terms of location, shape, and size, developing automatic segmentation methods has remained a challenging task over decades. This paper aims to review the evolution of automated models for brain tumor segmentation using multimodal MR images. In order to be able to make a just comparison between different methods, the proposed models are studied for the most famous benchmark for brain tumor segmentation, namely the BraTS challenge [1]. The BraTS 2012-2018 challenges and the state-of-the-art automated models employed each year are analysed. The changing trend of these automated methods since 2012 are studied and the main parameters that affect the performance of different models are analysed.

3 April 2014 in Human Brain Mapping
Verified
Journal Article
Closed access
PDF file
EBEsther E. Bron
Esther E. Bron
RSRebecca M.E. Steketee
Rebecca M.E. Steketee
GHGavin C. Houston
Gavin C. Houston
RORuth A. Oliver
Ruth A. Oliver
HAHakim C. Achterberg
Hakim C. Achterberg
FIFor The Alzheimer'S Disease Neuroimaging Initiative
For The Alzheimer'S Disease Neuroimaging Initiative

4 March 2015 in The Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
JWJanet R. Wade
Janet R. Wade
GPGerry Parker
Gerry Parker
GKGordana Kosutic
Gordana Kosutic
BFBrian G. Feagen
Brian G. Feagen
WSWilliam J. Sandborn
William J. Sandborn
RORuth Oliver
Ruth Oliver
Certolizumab pegol (CZP), an anti–tumor necrosis factor α agent, is an effective therapy for Crohn's disease (CD). A population pharmacokinetic (PK) analysis of subcutaneously administered CZP was performed using data from 2157 CD patients from 9 separate studies. The aim was to determine which covariates influence the disposition of CZP. The final CZP population PK model consisted of a baseline, first-order absorption, and 1-compartment disposition. CZP antibodies were treated as a structural model covariate and caused apparent clearance (CL/F) to increase from 0.685 to 2.74 L/day. Body surface area (BSA) influenced both CL/F and apparent volume of distribution (V/F) in a linear fashion; both parameters increased by more than 53% and 49%, respectively, across the range of BSA measurements in the data. Albumin influenced CZP CL/F in a nonlinear fashion; CL/F decreased from 1.05 to 0.613 L/day with increasing albumin concentrations in antibody-negative patients. C-reactive protein (CRP) had a borderline influence and CL/F increased by more than 20% across the range of CRP measurements in the data set. Race had a minor influence on V/F. The determined covariates' impact on CZP disposition may be of clinical utility in CZP therapy of CD patients when the PK/pharmacodynamic relationship becomes available.

1 February 2022 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
MGMina Ghaffari
Mina Ghaffari
GSGihan Samarasinghe
Gihan Samarasinghe
MJMichael Jameson
Michael Jameson
FAFarhannah Aly
Farhannah Aly
LHLois Holloway
Lois Holloway
RORuth Oliver
Ruth Oliver

23 April 2022
Verified
Book Chapter
Closed access
PDF file
AMAtul Singh Minhas
Atul Singh Minhas
RORuth Oliver
Ruth Oliver

1 September 2000 in Brain Research Bulletin
Verified
Journal Article
Closed access
KJKathrine Jauregui-Renaud
Kathrine Jauregui-Renaud
KYKielan Yarrow
Kielan Yarrow
RORuth Oliver
Ruth Oliver
MGMichael A Gresty
Michael A Gresty
ABAdolfo M Bronstein
Adolfo M Bronstein